Startup | February 10, 2022
Basf, Orbia Ventures invest in Israeli biotech startup
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
It would be the first protein-based alternative available in Israel
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Targeting deadly drug-resistant acinetobacter infections
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept
Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
